International Journal For Multidisciplinary Research

E-ISSN: 2582-2160   •   Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 6 Issue 6 November-December 2024 Submit your research before last 3 days of December to publish your research paper in the issue of November-December.
Submit Research Paper Join as a Reviewer

Plagiarism is checked by the leading plagiarism checker TurnItIn

Call for Paper

Volume 6 Issue 6
November-December 2024

Submit your research paper

Indexing Partners
Academia Advanced Sciences Index Bielefeld Academic Search Engine CiteSeer DRJI Google Scholar Independent Search Engine & Directory Network ISI (International Scientific Indexing) Issuu Mendeley Research Networks
RefSeek ResearcherId - Thomson Reuters ResearchGate Scirus Scribd Semantic Scholar UTeM - Universiti Teknikal Malaysia Melaka Wiki for Call for Papers WorldCat Zenodo

Exploring the Off-label Use of Botulinum Toxin in Hidradenitis Suppurativa

Author(s) Dhruv Nihal Gandhi, Veer Nihal Gandhi
Country India
Abstract Hidradenitis suppurativa (HS) is a therapeutic challenge despite various treatment modalities. This review explores the potential of botulinum toxin, both type A (BTX-A) and type B (BTX-B), as an off-label intervention for hidradenitis suppurativa management. Hidradenitis suppurativa, characterized by inflammatory lesions and abscesses, often leads to chronic pain and poor quality of life. Conventional therapies offer limited sustained relief, prompting exploration into alternative treatments.

Existing research, although primarily consisting of case reports and a limited randomized controlled trial, suggests potential benefits of botulinum toxin in alleviating HS symptoms. Observations include improvements in dermatology life quality index (DLQI), pain reduction, and lesion regression following botulinum toxin administration. However, these findings lack uniformity in dosing and demographic representation, necessitating further robust investigations encompassing diverse populations.

While initial findings hint at the promise of botulinum toxin as a potential therapeutic avenue for HS, the current evidence base is mainly anecdotal. Large-scale controlled trials across diverse demographics are crucial to substantiate efficacy, establish standardized treatment protocols, and evaluate the safety profile for broader application in managing this challenging condition.
Keywords Hidradenitis suppurativa, botulinum toxin, off-label use
Field Medical / Pharmacy
Published In Volume 5, Issue 6, November-December 2023
Published On 2023-12-25
Cite This Exploring the Off-label Use of Botulinum Toxin in Hidradenitis Suppurativa - Dhruv Nihal Gandhi, Veer Nihal Gandhi - IJFMR Volume 5, Issue 6, November-December 2023. DOI 10.36948/ijfmr.2023.v05i06.11132
DOI https://doi.org/10.36948/ijfmr.2023.v05i06.11132
Short DOI https://doi.org/gs98qf
View / Download PDF File

Share this



E-ISSN 2582-2160
CrossRef

CrossRef DOI is assigned to each research paper published in our journal.

IJFMR DOI prefix is
10.36948/ijfmr

Downloads
Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 6 Isu 6Cover Page Vol 6 Isu 5Cover Page Vol 6 Isu 4

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA Open Access

About IJFMR
Fees & Payment
Current Issue
Publication Archive 		Submit Research Paper
Track Submission Status
Publication Guidelines
Publication Ethics
Peer Review & Plagiarism 		Join as a Reviewer
Editors & Reviewers
Reviewer Referral Program
Get Reviewer Membership Certi. 		Website/Journal Policies
Usage Policy
Content Policies
Privacy Policy
Contact Us +91-9898-5948-55 editor@ijfmr.com